论文部分内容阅读
目的:探讨阀门植入术治疗新生血管性青光眼的疗效。方法:采用AHMED阀门植入术治疗15例(15只眼)新生血管性青光眼。随访6～42个月。结果:眼压由术前6.01±1.28 kPa(1 kPa=7.5mmHg)下降到术后的1.96±0.68 kPa。手术成功率为80.0％(0.80 kPa≤眼压≤2.80 kPa及无影响视力的严重并发症)。术后并发症主要包括前房出血、浅前房。结论:AHMED阀门植入术可有效地降低眼压,提高手术成功率,保护视功能,是治疗新生血管性青光眼的有效、安全的方法。眼科学报1998;14:87—89。
Objective: To investigate the effect of valve implantation in the treatment of neovascular glaucoma. Methods: Fifteen patients (15 eyes) with neovascular glaucoma were treated with AHMED valve implantation. Follow-up 6 to 42 months. Results: Intraocular pressure decreased from 6.01 ± 1.28 kPa (1 kPa = 7.5 mmHg) to 1.96 ± 0.68 kPa postoperatively. The operative success rate was 80.0% (0.80 kPa≤ IOP≤2.80 kPa and no serious complications affecting vision). Postoperative complications include anterior chamber bleeding, shallow anterior chamber. Conclusions: AHMED valve implantation can effectively reduce intraocular pressure, improve the success rate of operation and protect visual function. It is an effective and safe method for the treatment of neovascular glaucoma. Journal of Ophthalmology 1998; 14: 87-89.